about
Effectiveness of probiotics in type 2 diabetes: a meta-analysisIs aspirin resistance a real problem in people with type 2 diabetes?High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation studyAcetylsalicylic acid (ASA) use among Polish adults with diabetes mellitusMicroRNAs and metabolic disorders - where are we heading?Heart failure in the diabetic population - pathophysiology, diagnosis and management.Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cellsMetformin in cancer prevention and therapy.Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B.In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplastyEvaluation of oxidative stress markers in pathogenesis of diabetic neuropathy.Epigenetic modifications in adipose tissue - relation to obesity and diabetes.Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?Perspectives on the use of melatonin to reduce cytotoxic and genotoxic effects of methacrylate-based dental materials.Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.Molecular action of metformin in hepatocytes: an updated insight.Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells.Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells.DNA damage and repair in BCR/ABL-expressing cells after combined action of idarubicin, STI571 and amifostine.In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM).DNA damage and repair in type 2 diabetes mellitus.Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.Association of the 399Arg/Gln XRCC1, the 194 Arg/Trp XRCC1, the 326Ser/Cys OGG1, and the 324Gln/His MUTYH gene polymorphisms with clinical parameters and the risk for development of primary open-angle glaucoma.Erratum to "Is p53 Involved in Tissue-Specific Insulin Resistance Formation?"Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome.Endocrine pancreatic function in patients after acute pancreatitis.Free radical scavengers can modulate the DNA-damaging action of alloxan.Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.Aspirin dose increase from 75 to 150 mg suppresses red blood cell contribution to suboptimal platelet response to aspirin in patients with CAD.Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.Tumour protein 53 is linked with type 2 diabetes mellitus.SIRT1 as a therapeutic target in diabetic complications.Associations between DNA Damage, DNA Base Excision Repair Gene Variability and Alzheimer's Disease Risk.Analysis of oxidative DNA damage and its repair in Polish patients with diabetes mellitus type 2: Role in pathogenesis of diabetic neuropathy.
P50
Q26782612-80EDF03D-0683-4CBF-AD49-5647AE18E90BQ28168428-11E2EE45-EADF-45E5-BEEE-4E00524C4F45Q28195051-9AAC6E28-1AFC-4CEA-B5B3-BDC973378528Q28218158-6ADE3376-1886-4C4D-97A7-97FCE1ABBBB0Q33897355-BE40BE7E-5152-4A5A-A5DF-A9933E6FA3AAQ33935375-5E46D5AA-2885-4194-8AAB-3765A2AE8337Q34106145-CB217BF1-B063-4827-AB75-53D13A94BA53Q34357983-E90E3D58-F352-4582-951F-B33FC23D554FQ34418617-D7F1D3C6-D83B-453C-9E13-1A0FE5D07220Q34466743-8BEB7AC7-DC01-44A9-808D-F1216BE6F3F4Q36113708-BAC21A9E-89B1-4661-93CE-D9E2C2EC062DQ37416807-70265711-97F7-468B-997D-4D2CFBDBA5A0Q37615064-F3AE6F58-6E09-4283-A4FD-F4DF81D4AC14Q37737932-3C08D647-4926-45E1-B819-36DC135D4938Q37862366-44F55D19-101D-4C1B-9267-5F55CF4EB472Q38355958-A9D13BF0-0A1D-420D-9A4F-C5658AAEB2AFQ38390881-AAE4A849-A051-4B3C-AC07-2486D15B1821Q38781254-F7BE3A8F-F13E-4DC4-B19C-AC8D25013547Q40675131-2613420D-F0B1-43EC-89C1-DF987DCF39FFQ40681203-B0440166-065D-4BAE-A2C2-BBBB715FB732Q40688522-CACE77B2-EFBD-4733-A23D-0DECA79CC573Q40688994-16624584-DDF0-4573-AC90-BAE360D44EBBQ42436223-1230DF04-CC54-4FF3-85BD-26B2B506E4B8Q42468340-2BCF4331-B1D9-4FE7-A4D0-951BEC70E247Q42663436-18BAA6C0-A09F-430B-9C11-EDFB9636E635Q42692237-172A3685-E4CF-4D35-9D88-18BDF152154EQ42876644-B8D52680-713F-47FE-9AAA-41FAAD8F8A17Q44168053-18EAE4F7-9348-439B-B412-5BE0C87E1241Q44192649-59C0348E-4547-473F-982A-CA1C9EB33F37Q44389099-4C65B3F4-B9E7-4677-AC7D-5B1A8D7802B6Q44470904-4D56B08E-4774-4407-9711-80087228709EQ44490373-627FA41D-08C2-4516-A6CC-8C1C6F713CBBQ46249544-62C9492E-0CBA-41B8-9BC0-CF404E00BAFBQ46437192-FD6513BF-2C8B-4872-B0C8-F8F0A99B4772Q46445586-5E241505-A4B3-4018-84A6-CC61F9FC0452Q46788870-A30EA6C0-521A-4D0B-A89A-2661D46BA940Q47267222-A99F8FE0-F0E4-4C3D-82E4-6C11C58770C1Q47432670-86F3A52F-4681-45E3-B2EC-972E49892E43Q50684147-D437739C-0D25-417C-B211-0A61C2C1F3D0Q50852092-F85AF8D7-0EA3-475D-9879-2260BA99CA5A
P50
description
Polish diabetologist
@en
Pools onderzoeker
@nl
cercetător polonez
@ro
chercheur polonais
@fr
investigador polaco
@es
investigador polaco
@gl
investigador polonès
@ca
polnischer Arzt
@de
polski lekarz, diabetolog
@pl
ricercatore polacco
@it
name
Józef Drzewoski
@ast
Józef Drzewoski
@ca
Józef Drzewoski
@de
Józef Drzewoski
@en
Józef Drzewoski
@es
Józef Drzewoski
@fr
Józef Drzewoski
@ga
Józef Drzewoski
@gl
Józef Drzewoski
@it
Józef Drzewoski
@nl
type
label
Józef Drzewoski
@ast
Józef Drzewoski
@ca
Józef Drzewoski
@de
Józef Drzewoski
@en
Józef Drzewoski
@es
Józef Drzewoski
@fr
Józef Drzewoski
@ga
Józef Drzewoski
@gl
Józef Drzewoski
@it
Józef Drzewoski
@nl
altLabel
Jozef Drzewoski
@en
prefLabel
Józef Drzewoski
@ast
Józef Drzewoski
@ca
Józef Drzewoski
@de
Józef Drzewoski
@en
Józef Drzewoski
@es
Józef Drzewoski
@fr
Józef Drzewoski
@ga
Józef Drzewoski
@gl
Józef Drzewoski
@it
Józef Drzewoski
@nl
P214
P106
P1412
P1559
Józef Drzewoski
@pl
P21
P214
P27
P31
P3124
P735
P7859
lccn-no98101884